Overview

Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
Oral mucositis (OM) is an acute side effect of radiotherapy for head and neck cancer (HNC). OM associated pain affects oral functions and nutrition of the patient that may result in discontinuity of treatment.The purpose of this clinical study is to evaluate the therapeutic effects of Compound Kushen Injection (CKI) on oral mucositis caused by radiotherapy of head and neck cancer.
Phase:
Phase 4
Details
Lead Sponsor:
Shanxi Zhendong Pharmacy Co., Ltd
Treatments:
Levofloxacin
Ofloxacin